Your browser doesn't support javascript.
loading
Corrigendum to "Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis" [Lung Cancer 68 (1) (2010) 27-38].
Zhuang, Hongqin; Jiang, Weiwei; Cheng, Wei; Qian, Kui; Dong, Wei; Cao, Lin; Huang, Qilai; Li, Shufeng; Dou, Fei; Chiu, Jen-Fu; Fang, Xue-Xun; Lu, Min; Hua, Zi-Chun.
Afiliación
  • Zhuang H; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Jiang W; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Cheng W; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Qian K; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Dong W; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China; Department of Chemistry, The School of Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210
  • Cao L; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Huang Q; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Li S; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China; College of Basic Medical Science, Southeast University, Nanjing, 210093, Jiangsu, PR China.
  • Dou F; College of Basic Medical Science, Southeast University, Nanjing, 210093, Jiangsu, PR China.
  • Chiu JF; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China; Department of Anatomy, The University of Hong Kong, Hong Kong, China.
  • Fang XX; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China; Key Laboratory of Molecular Enzymology and Enzyme Engineering of Ministry Education, Jilin University, Changchun, 13002
  • Lu M; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China.
  • Hua ZC; Jiangsu Center of Hepatobiliary Diseases, The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210093, Jiangsu, PR China; Changzhou High-Tech Research Institute of Nanjing University, Changzhou, 213164, Jiangsu, PR China. Electronic address:
Lung Cancer ; 141: 119-120, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31955911
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article